Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Cortellini, A; D'Alessio, A; Cleary, S; Buti, S; Bersanelli, M; Bordi, P; Tonini, G; Vincenzi, B; Tucci, M; Russo, A; Pantano, F; Russano, M; Stucci, LS; Sergi, MC; Falconi, M; Zarzana, MA; Santini, D; Spagnolo, F; Tanda, ET; Rastelli, F; Giorgi, FC; Pergolesi, F; Giusti, R; Filetti, M; Lo Bianco, F; Marchetti, P; Botticelli, A; Gelibter, A; Siringo, M; Ferrari, M; Marconcini, R; Vitale, MG; Nicolardi, L; Chiari, R; Ghidini, M; Nigro, O; Grossi, F; De Tursi, M; Di Marino, P; Queirolo, P; Bracarda, S; Macrini, S; Inno, A; Zoratto, F; Veltri, E; Spoto, C; Vitale, MG; Cannita, K; Gennari, A; Morganstein, DL; Mallardo, D; Nibid, L; Sabarese, G; Brunetti, L; Perrone, G; Ascierto, PA; Ficorella, C; Pinato, DJ

Cortellini, A (通讯作者),Fdn Policlin Univ Campus Biomed, Via Alvaro del Portillo 200, I-00128 Rome, Italy.;Pinato, DJ (通讯作者),Imperial Coll London, Med Oncol, Hammersmith Campus,Du Cane Rd, London W12 0HS, England.;Pinato, DJ (通讯作者),Imperial Coll London, Dev Canc Therapeut, Hammersmith Campus,Du Cane Rd, London W12 0HS, England.

CLINICAL CANCER RESEARCH, 2023; 29 (14): 2714